EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Natural compounds targeting inflammatory signaling and cell adhesion molecules in ischemic acute kidney injury

Sally A Fahim, Ahmed M El-Dessouki, Nada Osama, Sherif S Abdel Mageed, Mahrous H Mahrous, Reham A Mohammed, Ahmed S Kamel, Kareem Abdou, Joon Hyung Yeo, Riham A El-Shiekh, Nehal I Rizk

Archives of Pharmacal Research · 2026-05 · 49 (5) · 577-635

DOI: 10.1007/s12272-026-01601-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archives of Pharmacal Research, online erschienen am 26.04.2026. Verfasst von Sally A Fahim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, School of Pharmacy, Newgiza University (NGU), Km 22 Cairo-Alexandria Desert Road, Newgiza, 12577, Giza, Egypt. Hauptthemen laut MEDLINE: Acute Kidney Injury, Cell Adhesion Molecules, Inflammation, Biological Products. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 263 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cairo University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemic acute kidney injury (AKI) remains a major clinical challenge, characterized by high morbidity, mortality, and a substantial risk of progression to chronic kidney disease. Accumulating evidence indicates that ischemic AKI is not merely a transient hemodynamic disorder but a complex, biologically orchestrated process driven by microvascular dysfunction, innate immune activation, inflammatory signaling, and maladaptive tissue repair. Despite advances in supportive care, effective disease-modifying therapies are still lacking. Recent studies have highlighted that key signaling pathways, including Toll-like receptor/nuclear factor-κB (TLR/NF-κB), Janus kinase/signal transducer and activator of transcription (JAK/STAT), purinergic P2X7 receptor–inflammasome signaling, heat-shock protein–mediated stress responses, and phosphoinositide 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) cascades, govern the initiation, amplification, and resolution of ischemic renal injury. These pathways converge on downstream cellular effectors such as cell adhesion molecules (CAMs), which orchestrate leukocyte recruitment, endothelial-epithelial interactions, and spatial propagation of inflammation within the renal microvasculature. Natural compounds have emerged as promising therapeutic candidates for ischemic AKI due to their pleiotropic pharmacological properties and ability to modulate multiple pathogenic signaling networks simultaneously. A growing body of experimental evidence demonstrates that polyphenols, glycosides, saponins, and related phytochemicals attenuate ischemic renal injury by suppressing inflammatory signaling, reducing CAM expression, preserving microcirculatory integrity, and promoting adaptive repair. Furthermore, advances in nanocarrier-based delivery systems have substantially enhanced the translational potential of these compounds by improving bioavailability, renal targeting, and pathway-specific modulation. In this review, we provide a comprehensive, signaling-centered analysis of ischemic AKI pathogenesis and systematically map natural compounds to their molecular targets and downstream inflammatory effectors. By integrating mechanistic insights with emerging nanotherapeutic strategies, this work offers a structured framework for the rational development of multi-target, mechanism-based interventions for ischemic AKI. It highlights key challenges and future directions for clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryCell Adhesion MoleculesInflammationBiological ProductsIschemiaHumansAnimalsSignal Transduction

Stichwörter der Autor:innen

Cell adhesion moleculesInflammatory signaling pathwaysIschemic acute kidney injuryNanocarrier-based therapyNatural compoundsRenal microcirculation

Substanzen

Cell Adhesion MoleculesBiological Products

Autor:innen und Institutionen

  • Department of Biochemistry, School of Pharmacy, Newgiza University (NGU), Km 22 Cairo-Alexandria Desert Road, Newgiza, 12577, Giza, Egypt.
  • Pharmacology and Toxicology Department, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, 12566, Giza, Egypt.
  • Biochemistry Department, Faculty of Pharmacy, Menoufia University, Gamal Abd El Nasr St., Shibin Elkom, 32511, Menoufia, Egypt.
  • Pharmacology Department, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City , 11829, Cairo, Egypt.
  • Department of Pharmacognosy, Faculty of Pharmacy, Delta University for Science and Technology, Dakhliya, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, 11562, Egypt.

Förderung

  • Cairo University

Zitieren

APA

Fahim, S. A., El-Dessouki, A. M., Osama, N., Mageed, S. S. A., Mahrous, M. H., Mohammed, R. A., Kamel, A. S., Abdou, K., Yeo, J. H., El-Shiekh, R. A., & Rizk, N. I. (2026). Natural compounds targeting inflammatory signaling and cell adhesion molecules in ischemic acute kidney injury. Archives of Pharmacal Research, 49(5), 577-635. https://doi.org/10.1007/s12272-026-01601-4

Vancouver

Fahim SA, El-Dessouki AM, Osama N, Mageed SSA, Mahrous MH, Mohammed RA, et al. Natural compounds targeting inflammatory signaling and cell adhesion molecules in ischemic acute kidney injury. Archives of Pharmacal Research. 2026;49(5):577-635. doi:10.1007/s12272-026-01601-4

BibTeX
@article{Fahim2026,
  author = {Fahim, Sally A and El-Dessouki, Ahmed M and Osama, Nada and Mageed, Sherif S Abdel and Mahrous, Mahrous H and Mohammed, Reham A and Kamel, Ahmed S and Abdou, Kareem and Yeo, Joon Hyung and El-Shiekh, Riham A and Rizk, Nehal I},
  title = {Natural compounds targeting inflammatory signaling and cell adhesion molecules in ischemic acute kidney injury},
  journal = {Archives of Pharmacal Research},
  year = {2026},
  volume = {49},
  number = {5},
  pages = {577--635},
  doi = {10.1007/s12272-026-01601-4}
}
Kostenlos starten →